This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.Need a new registration confirmation email? Click here

Mednax(MD) estimates, target raised at Piper. Shares of MD now seen reaching $91, according to Piper Jaffray. Estimates also increased, given Medicare rate parity. Overweight rating.

MarketAxess(MKTX) numbers increased at BMO. MKTX estimates were raised through 2014, BMO Capital said. Company is leveraged to higher cash credit activity and is also taking market share. Market Perform rating and new $34 price target.

AT&T(T - Get Report) estimates, target cut at Guggenheim. Shares of T now seen reaching $33.50, according to Guggenheim. Estimates also reduced, given higher expected smartphone subsidies. Neutral rating.

Vera Bradley(VRA) numbers raised at Jefferies. Shares of VRA now seen reaching $22, Jefferies said. Estimates also raised on all around solid quarter. Hold rating.

Verint(VRNT) estimates, target lowered at JP Morgan. Shares of VRNT now seen reaching $35.50, according to JP Morgan. Estimates also cut, given a weaker business mix and slower growth in Europe. Overweight rating.

Verint Systems numbers lowered at Oppenheimer. Shares of VRNT now seen reaching $41, Oppenheimer said. Estimates also lowered on near- term headwinds in Europe. Outperform rating.

Product Features:

To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.